-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Events
eAdvocacy Summit Brings Together More Than 130 Groups
BIO’s mission is to champion biotechnology issues by advocating for policies that will enable the realization of breakthrough products to cure disease, feed the hungry, and clean our environment. Fortunately, we are not alone – our many alliance and advocacy partners share our goal. When smart, like-minded people get together, good things tend to happen. That’s why I’m looking forward to tomorrow’s eAdvocacy Summit here in Washington, DC. The Global Healthy Living Foundation (GHLF) and Read More >
BIO Investor Forum – Raring to Go: The Race to Treat Ultra-Rare Diseases
The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline. In anticipation of an even more compelling opportunity, many companies are taking a step beyond and focusing on ultra rare diseases. Last week’s 11th Annual BIO Investor Forum in San Francisco hosted a panel, Raring Read More >
BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable
During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >
Jim Greenwood Shares his Thoughts on BIO India
As a non-profit trade association that represents the biotech industry, BIO is pleased to bring the BIO International Conference back to India in an effort to further create and drive business development and collaborations between the US and Indian industry in all areas relating to biotechnology. The conference, which will be held in Mumbai this year on September 12-13, brings together global business and thought leaders in the various areas of biotechnology for partnering. For Read More >
2012 Fall Event Preview
The 2012 BIO International Convention, the global event for biotechnology, held at the Boston Convention & Exhibition Center in Boston, Mass., wrapped this June. The event hosted a record 25,291 partnering meetings and highlighted a broad array of top-level speakers addressing critical global challenges and the top issues in biotechnology. Hosted by the Biotechnology Industry Organization (BIO), the event drew 16,505 industry leaders from 49 states and 65 countries. See what BIO President and CEO Jim Greenwood Read More >
